Invesaro

Stocks HON Financial statements

Financial statements

HONEYWELL INTERNATIONAL INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data HONEYWELL INTERNATIONAL INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2020FY2022FY2023FY2024FY2025
Revenue39,30240,53441,80236,70932,63734,39235,46633,00934,71737,442
Cost of revenue27,67728,14429,04624,33922,16922,06122,34720,63721,36023,613
Gross profit12,15212,39012,75612,37010,46812,33113,11912,37213,35713,829
Research and development1,8641,8351,8091,5561,3341,3331,4781,3751,4541,812
Selling, general and administrative5,5746,0876,0515,5194,7724,7985,2144,8875,2355,450
Operating income8,0227,5637,6678,127
Interest expense3383163673573593434147491,0481,344
Interest income106151217255107102138321430369
Other non-operating income7399631,1491,0656751,3783668308431,247
Pre-tax income6,4526,9507,4877,5596,0127,2356,3796,1916,2445,476
Income tax1,6035,3626591,3291,1471,6251,4121,2621,2491,008
Income from continuing operations4,9134,9684,461
Net income to minority interests3743638786681143543
Net income4,8121,5456,7656,1434,7795,5424,9665,6585,7054,729
EBITDA9,2268,5678,8209,515
EPS, basic6.302.039.108.526.798.017.338.538.767.40
EPS, diluted6.212.008.988.416.727.917.278.478.717.36
Shares, basic (weighted)764762743721704692677663651639
Shares, diluted (weighted)775772753730711700683668655643
Dividend per share2.452.743.063.363.633.773.974.174.374.58

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2020FY2022FY2023FY2024FY2025
Cash and equivalents7,8437,0599,2879,06714,27510,9599,6277,9259,90612,273
Short-term investments1,5203,7581,6231,349945564483170386443
Receivables8,1778,8667,5087,4936,8276,8307,4407,5307,2474,429
Inventory4,3664,6134,3264,4214,4895,1385,5386,1785,8841,677
Other current assets1,1521,7061,6181,9731,6391,8811,8941,6991,259841
Total current assets23,05826,00224,36224,30328,17525,37224,98223,50227,90830,387
Property, plant and equipment5,7935,9265,2965,3255,5705,5625,4715,6604,4572,466
Lease right-of-use assets6737739478811,004936630
Goodwill17,70718,27715,54615,56316,05817,75617,49717,23821,01918,054
Intangible assets4,6344,4964,1393,7343,5603,6133,2223,2316,6215,161
Other non-current assets1,6033,3726,8698,6889,41210,1349,5139,58210,5564,537
Total assets54,56659,47057,77358,67964,58664,47062,27561,52575,19673,681
Accounts payable5,6906,5845,6075,7305,7506,4846,3296,8496,1093,434
Accrued liabilities7,0486,9686,8597,4767,4057,6799,1627,8098,0555,063
Deferred revenue2,4032,4902,9323,1633,5553,4993,4293,860
Short-term debt2271,3512,8721,3762,4451,8031,7301,7961,3251,541
Total current liabilities16,33118,86118,92418,09819,19719,50819,93818,53921,25623,414
Long-term debt12,18212,5739,75611,11016,34214,25415,12316,56225,44027,137
Lease liabilities0534641847775897863581
Other non-current liabilities4,1105,9306,4026,7666,9757,0876,4696,2655,5813,986
Total liabilities35,26342,80539,41539,97346,79645,22844,95645,09156,04258,651
Total debt12,40913,92412,62812,48618,78716,05716,85318,35826,82628,678
Paid-in capital5,7816,2126,4526,8767,2928,1418,5649,0629,69510,636
Retained earnings28,71027,48133,97837,69339,90542,82745,09347,97950,83550,964
Treasury stock-13,366-15,914-19,771-23,836-27,229-30,462-34,443-38,008-39,378-43,029
Other comprehensive income-2,714-2,235-3,437-3,197-3,377-2,895-3,475-4,135-3,491-5,146
Shareholders' equity19,36916,50218,18018,49417,54918,56916,69715,85618,61913,904
Minority interests1781631782122416736225785351,126
Total equity18,88316,66518,35818,70617,79019,24217,31916,43419,15415,030
Total liabilities and equity54,14659,47057,77358,67964,58664,47062,27561,52575,19673,681
Shares outstanding761751730711697685668652650635

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2020FY2022FY2023FY2024FY2025
Net income4,8491,5886,8286,2304,8655,6104,9675,6725,7404,772
Depreciation and amortization1,0301,1151,1161,0881,0031,1381,2041,0041,1531,388
Stock-based compensation184176175153168217188197189196
Deferred income tax782,452-586179-175178-180189-22918
Change in receivables-547-682-23611669-8-73967-129-825
Change in inventory-18-259-503-100-67-685-440-549-286-636
Change in payables25492473311815744-15544478724
Cash from operations5,4985,9666,4346,8976,2086,0385,2745,3406,0976,408
Capital expenditures-1,095-1,031-828-839-906-895-766-741-871-986
Acquisitions-2,573-82-535-50-261-1,326-178-718-8,880-2,211
Purchases of investments-3,954-6,743-4,059-4,253-3,236-2,373-1,211-560-1,077-1,503
Sales and maturities of investments3,6814,4146,0324,4643,5082,5251,2559718701,469
Cash from investing-3,342-3,5741,027-533-987-1,061-93-1,293-10,157-2,711
Share buybacks-2,079-2,889-4,000-4,400-3,714-3,380-4,200-3,715-1,655-3,804
Dividends paid-1,915-2,119-2,272-2,442-2,592-2,626-2,719-2,855-2,902-2,976
Cash from financing346-3,516-5,032-6,600-81-8,254-6,330-5,7636,839-1,953
Exchange rate effect-114340-201
Net change in cash2,388-7842,228-2205,208-3,316-1,332-1,7022,6421,920
Free cash flow4,4034,9355,6066,0585,3025,1434,5084,5995,2265,422
Interest paid3293063533443293393756498691,300
Income taxes paid1,1421,7511,5661,5641,1731,2021,3241,5811,6891,798

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to September 30, 2026; growth uses fiscal years. Valuation uses the share price of $228.22 on November 10, 2026.

Profitability

MetricValueHow it is calculated
Gross margin37.7%Gross profit / revenue.
Operating margin32.7%Operating income / revenue.
EBITDA margin37.5%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin37.0%Pre-tax income / revenue.
Net margin21.0%Net income / revenue.
FCF margin2.9%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin5.8%Cash from operations / revenue.
Effective tax rate18.6%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)31.5%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)13.3%Net income / average total assets.
Return on invested capital (ROIC)29.0%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue6.8%Research and development expense / revenue.
SG&A / revenue17.2%Selling, general and administrative expense / revenue.
Stock-based pay / revenue-0.1%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue2.9%Capital expenditures / revenue.
D&A / revenue4.8%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y7.8%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y1.8%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y2.8%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y3.5%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y1.8%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y5.7%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y6.0%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y0.4%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y7.9%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y1.0%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y-17.1%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-1.6%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y-0.2%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y-15.5%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y0.4%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y1.8%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y5.1%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y6.7%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y0.6%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y3.8%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y6.3%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y0.4%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y4.8%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y4.9%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y4.8%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-25.3%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-5.9%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-4.5%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-2.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y5.8%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y2.7%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-1.9%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-2.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-2.0%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.96xCurrent assets / current liabilities.
Quick ratio0.76x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.41x(Cash + short-term investments) / current liabilities.
Debt / equity0.63xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets26.7%Total debt / total assets.
Liabilities / assets57.3%Total liabilities / total assets.
Net debt$7.98BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA0.63xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage8.90xOperating income / interest expense.
Working capital-$595.0MCurrent assets - current liabilities.
Goodwill and intangibles / assets43.3%(Goodwill + intangible assets) / total assets.
Tangible book value-$586.0MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.63xRevenue / average total assets.
Fixed asset turnover12.4xRevenue / average property, plant and equipment.
Inventory turnover14.3xCost of revenue / average inventory.
Days inventory26 days365 x average inventory / cost of revenue.
Receivables turnover6.61xRevenue / average receivables.
Days sales outstanding55 days365 x average receivables / revenue.
Days payables45 days365 x average accounts payable / cost of revenue.
Cash conversion cycle36 daysDays inventory + days sales outstanding - days payables.
FCF conversion13.7%Free cash flow / net income, when net income is positive.
Capex / operating cash flow50.3%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$21.02Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$105.31Revenue / diluted weighted shares.
FCF per share$3.03Free cash flow / diluted weighted shares.
Operating cash flow per share$6.10Cash from operations / diluted weighted shares.
Book value per share$70.63Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$1.85Tangible book value / shares outstanding.
Cash per share$19.49(Cash + short-term investments) / shares outstanding.
Payout ratio36.6%Dividends paid / net income, when net income is positive.
Dividends / FCF266.6%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF113.8%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$72.33BShare price x shares outstanding.
Enterprise value$80.32BMarket cap + total debt - cash - short-term investments.
P/E10.3xMarket cap / net income. Only when net income is positive.
P/S2.15xMarket cap / revenue.
P/B3.23xMarket cap / shareholders' equity. Only when equity is positive.
P/FCF74.8xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF37.2xMarket cap / cash from operations, when positive.
EV/Sales2.39xEnterprise value / revenue.
EV/EBIT7.30xEnterprise value / operating income, when both are positive.
EV/EBITDA6.38xEnterprise value / EBITDA, when both are positive.
EV/FCF83.1xEnterprise value / free cash flow, when both are positive.
FCF yield1.3%Free cash flow / market cap.
Earnings yield9.7%Net income / market cap (the inverse of P/E).
Dividend yield3.6%Dividends paid over the period / market cap.
Shareholder yield5.1%(Dividends paid + share buybacks) / market cap.
PEG25.0xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was HONEYWELL INTERNATIONAL INC's revenue in fiscal 2025?

HONEYWELL INTERNATIONAL INC reported revenue of $37.44B for fiscal 2025, 7.8% higher than the year before.

Was HONEYWELL INTERNATIONAL INC profitable in fiscal 2025?

Yes. Net income was $4.73B, a net margin of 12.6%.

How much free cash flow did HONEYWELL INTERNATIONAL INC generate in fiscal 2025?

Cash from operations of $6.41B minus capital expenditures of $986.0M left free cash flow of $5.42B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to HONEYWELL INTERNATIONAL INC